(Q39878275)

15 September 2017

Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9. (English)

1 reference

15 September 2017

0 references

1 reference

A H Elmaagacli

1

1 reference

15 September 2017

M Koldehoff

series ordinal

2

1 reference

15 September 2017

D W Beelen

series ordinal

3

1 reference

15 September 2017

language of work or name

English

0 references

publication date

2 March 2009

1 reference

Bone Marrow Transplantation

15 September 2017

1 reference

15 September 2017

44

1 reference

15 September 2017

5

1 reference

15 September 2017

295-302

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2009.32

15 September 2017

0 references

cites work

Toll-like receptors and innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

The Toll receptor family and microbial recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Ligand-induced conformational changes allosterically activate Toll-like receptor 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Sequence requirements for oligodeoxyribonucleotide inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Toll-like receptor 9 (TLR9) agonists in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

7 January 2021

Putative association of a TLR9 promoter polymorphism with atopic eczema.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

7 January 2021

Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

7 January 2021

Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

7 January 2021

Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

7 January 2021

Critical role of TLR9 in acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.32

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.32

1 reference

15 September 2017

1 reference